首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   30401篇
  免费   2508篇
  国内免费   55篇
耳鼻咽喉   155篇
儿科学   1112篇
妇产科学   1001篇
基础医学   4057篇
口腔科学   493篇
临床医学   4130篇
内科学   5484篇
皮肤病学   369篇
神经病学   3542篇
特种医学   560篇
外科学   2941篇
综合类   459篇
一般理论   57篇
预防医学   3639篇
眼科学   640篇
药学   2046篇
中国医学   33篇
肿瘤学   2246篇
  2023年   240篇
  2022年   257篇
  2021年   524篇
  2020年   414篇
  2019年   648篇
  2018年   681篇
  2017年   552篇
  2016年   575篇
  2015年   661篇
  2014年   924篇
  2013年   1366篇
  2012年   2013篇
  2011年   2096篇
  2010年   1097篇
  2009年   1048篇
  2008年   1836篇
  2007年   1899篇
  2006年   1930篇
  2005年   1808篇
  2004年   1788篇
  2003年   1708篇
  2002年   1588篇
  2001年   603篇
  2000年   545篇
  1999年   495篇
  1998年   322篇
  1997年   287篇
  1996年   235篇
  1995年   227篇
  1994年   175篇
  1993年   191篇
  1992年   295篇
  1991年   299篇
  1990年   254篇
  1989年   241篇
  1988年   229篇
  1987年   227篇
  1986年   185篇
  1985年   196篇
  1984年   133篇
  1983年   144篇
  1982年   130篇
  1981年   112篇
  1980年   116篇
  1979年   151篇
  1978年   116篇
  1977年   103篇
  1976年   101篇
  1974年   108篇
  1972年   93篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
The serrated pathway (SP) can be viewed as two parallel, but partially overlapping, arrays of colorectal precursor lesions, and their respective endpoint carcinomas, that are distinct from those of the conventional adenoma–carcinoma sequence (APC‐pathway). In this review we focus at the outset on the clinical impact, pathological features, molecular genetics and biological behaviours of the various SP cancers. Then we summarize the clinicopathological features, classification and molecular profiles of the two main precursor lesions that anchor the respective pathways: (i) sessile serrated adenoma/polyp (SSA/P), also called sessile serrated lesion (SSL), and (ii) traditional serrated adenoma (TSA). Activating mutations of the RAS–RAF–MAPK pathway initiate and sustain the lesions of the SP, and CpG island methylation of the promoter regions of tumour suppressor and DNA repair genes play the major role in their neoplastic progression. The SP includes microsatellite stable (MSS) carcinomas that are among the most biologically aggressive colorectal carcinomas (CRC), and also accounts for the great preponderance of sporadic hypermutated, mismatch repair (MMR)‐deficient or microsatellite instable (MSI) CRC. The identification, removal and appropriate classification of at‐risk SP precursors and surveillance of individuals who harbour these lesions present a challenge and opportunity for CRC prevention and mortality reduction.  相似文献   
7.
8.
9.
10.
Ticagrelor is a cornerstone of modern antithrombotic therapy alongside aspirin in patients with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects such as bleeding and dyspnea have been associated with premature ticagrelor discontinuation, which may limit any potential advantage of ticagrelor over clopidogrel. The randomized trials of ticagrelor captured adverse events, offering the opportunity to more precisely quantify these effects across studies. Therefore, a meta-analysis of 4 randomized clinical trials of ticagrelor conducted between January 2007 and June 2017 was performed to quantify the incidence and causes of premature ticagrelor discontinuation. Among 66,870 patients followed for a median 18 months, premature ticagrelor discontinuation was seen in 25%; bleeding was the most common cause of discontinuation followed by dyspnea. Versus the comparators, the relative risk of dyspnea-related discontinuation during follow-up was 6.4-fold higher, the relative risk of bleeding was 3.2-fold higher, and the relative risk of discontinuation due to any adverse event was 59% higher for patients receiving ticagrelor. Understanding these potential barriers to adherence to ticagrelor is crucial for informed patient-physician decision making and can inform future efforts to improve ticagrelor adherence. This review discusses the incidence, causes, and biological mechanisms of ticagrelor-related adverse effects and offers strategies to improve adherence to ticagrelor.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号